**A report by MedCity ranks London as the number one city in Europe and the third city globally for life sciences.**
The _Global Cities Comparison Report_, released by the life sciences cluster organisation late last year, ahead of London Life Sciences Week, benchmarks 20 global cities across five key areas:
* Research innovation
* Health research environment
* Talent ecosystem
* Investment environment
* Business environment.
London had the highest global ranking for health research environment. The city offers more than 35 biomedical research centres and serves one of the world’s most diverse populations, with more than 40% of its 8.9 million residents identifying with either Asian, black, mixed or other ethnic groups. In combination with its integrated digital health systems and supportive regulatory body, the report found this makes the city an attractive destination for health research and drug development.
The UK capital claimed second place for research innovation, following closely behind Boston. London is home to three universities that are ranked among the top 15 globally for clinical and health sciences, as well as a significant number of Nobel Prize-winning scientists. Additionally, the city’s life sciences research community is known for its high volume of publications and active participation in international research collaborations outside the US.
London was also ranked number two for business environment, ahead of New York. The UK capital is considered a prime location for life sciences businesses, with its ecosystem of more than 2,400 life sciences companies, international connectivity, sustainability commitments and low operational risk.
Read the article in full [here](https://pmlive.com/digital_edition/pme/pharmaceutical-market-europe-march-2025/).